UK Companies House feature
SWEDISH ORPHAN BIOVITRUM LTD
Profile
- Company number
- 04369760
- Status
- Active
- Incorporation
- 2002-02-08
- Last accounts made up
- 2024-12-31
- Account category
- FULL
- Primary SIC
- 21200
- Hubs
- UK Healthcare
Accounts
Pending extraction
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- Ernst & Young LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“As a wholly-owned subsidiary of the parent company, Swedish Orphan Biovitrum AB (Sobi AB), cash is managed through a group cash pooling arrangement. The company is therefore reliant on support from its parent and has obtained confirmation from its parent that it will continue to provide the necessary financial support to ensure the company is able to continue as a going concern, for the going concern period. The Directors have compiled a budget and cash flow forecast for the period to 31 December 2026 being the going concern review period based on levels of trading observed to date in 2025, and taking into account the pricing and funding arrangements between the company and its parent. The Directors remain confident in the existing product portfolio as well as anticipated revenues from products currently in the launch plan, and have set targets for the coming year based on anticipated revenue growth. No significant capital expenditure is anticipated in the review period. As such, the Directors perceive no significant cash flow risk to the business. The Sobi group continues to perform strongly throughout the world and record sales and profit growth year on year. This, combined with the financial support from Swedish Orphan Biovitrum AB, provides the Directors with assurance that the business can expect to continue as a going concern for the period to 31 December 2026. The Directors have made enquiries of its parent undertaking and are comfortable that the parent has the ability to provide financial support as needed.”
Significant events
- “There have been no significant events affecting the company since the reporting date.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
4 active · 22 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| KNOTT, Steve Wesley Andrew | Secretary | 2024-11-29 | — | — |
| FAHMY, Soufiane | Director | 2020-11-02 | Apr 1972 | French |
| HALL, Sharon | Director | 2023-03-02 | Nov 1970 | British |
| STENQVIST, Henrik | Director | 2018-07-20 | Apr 1967 | Swedish |
Show 22 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BLOM, Mats Peter | Secretary | 2007-11-12 | 2010-04-27 |
| COX, Simon Edward | Secretary | 2019-11-30 | 2024-11-29 |
| LAINE, Janne | Secretary | 2005-04-30 | 2007-09-27 |
| OSTANSJO, Par | Secretary | 2002-03-22 | 2005-04-30 |
| SWIFT INCORPORATIONS LIMITED | Corporate Nominee Secretary | 2002-02-08 | 2002-03-22 |
| COX, Simon Edward | Director | 2022-10-14 | 2023-03-02 |
| COX, Simon Edward | Director | 2020-03-11 | 2021-02-01 |
| DREGER, Christian Michael | Director | 2019-01-01 | 2019-11-11 |
| DUGDALE, Neil Alan | Director | 2015-06-22 | 2020-03-31 |
| EDVELL, Anders | Director | 2011-01-01 | 2012-04-24 |
| FAULKNER DUNKLEY, Bruce | Director | 2006-10-23 | 2015-06-22 |
| HANSEN, Bo Jesper | Director | 2002-03-22 | 2010-04-27 |
| HELLSTRÖM, Hege | Director | 2017-07-06 | 2018-12-31 |
| LAINE, Janne | Director | 2005-04-30 | 2007-04-27 |
| MCDONOUGH, Cameron Geoffrey | Director | 2011-08-15 | 2015-06-22 |
| NIKLASSON, Martin Alf Gunnar | Director | 2010-04-27 | 2011-01-01 |
| OLIVER, Michael | Director | 2021-02-01 | 2022-10-14 |
| RAFFENSPERGER, Alan Henry | Director | 2012-04-24 | 2017-07-05 |
| ROOTH, Kennet | Director | 2006-10-23 | 2011-08-15 |
| WALLIN, Mats-Olof | Director | 2015-06-22 | 2018-07-20 |
| WOOD, Philip | Director | 2019-12-06 | 2020-11-02 |
| INSTANT COMPANIES LIMITED | Corporate Nominee Director | 2002-02-08 | 2002-03-22 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Swedish Orphan Biovitrum International Ab (Publ) | Corporate entity | Shares 75–100% | 2016-04-06 | Active |
Filing timeline
Last 20 of 117 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2026-02-23 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2025-09-16 | AA | accounts | accounts with accounts type full |
| 2025-03-07 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-11-29 | TM02 | officers | termination secretary company with name termination date |
| 2024-11-29 | AP03 | officers | appoint person secretary company with name date |
| 2024-10-11 | AA | accounts | accounts with accounts type full |
| 2024-03-13 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2023-10-13 | AA | accounts | accounts with accounts type full |
| 2023-03-02 | AP01 | officers | appoint person director company with name date |
| 2023-03-02 | TM01 | officers | termination director company with name termination date |
| 2023-03-01 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2022-10-14 | AP01 | officers | appoint person director company with name date |
| 2022-10-14 | TM01 | officers | termination director company with name termination date |
| 2022-10-05 | AA | accounts | accounts with accounts type full |
| 2022-02-17 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2022-02-01 | AA | accounts | accounts with accounts type full |
| 2021-06-08 | TM01 | officers | termination director company with name termination date |
| 2021-02-10 | AP01 | officers | appoint person director company with name date |
| 2021-02-09 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2021-02-03 | AA | accounts | accounts with accounts type full |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory